All Stories

  1. Identification of a Novel miR-122-5p/CDC25A Axis and Potential Therapeutic Targets for Chronic Myeloid Leukemia

    Article • International Journal of Molecular Sciences, November 2025, MDPI AG

    Tatjana Srdic-Rajic

  2. Nischarin agonist rilmenidine shows antimetastatic potential in pancreatic ductal adenocarcinoma

    Article • October 2025, Cold Spring Harbor Laboratory Press

    Tatjana Srdic-Rajic

  3. Redox-dependent metabolic alterations underlying chemosensitivity in HL-60 and K562 leukemia cells

    Article • January 2025, Centre for Evaluation in Education and Science (CEON/CEES)

    Tatjana Srdic-Rajic

  4. Unveiling the 4-aminoquinoline derivatives as potent agents against pancreatic ductal adenocarcinoma (PDAC) cell lines

    Article • Chemico-Biological Interactions, December 2024, Elsevier

    Tatjana Srdic-Rajic

  5. Screening Algal and Cyanobacterial Extracts to Identify Potential Substitutes for Fetal Bovine Serum in Cellular Meat Cultivation

    Article • Foods, November 2024, MDPI AG

    Tatjana Srdic-Rajic

  6. Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design

    Article • Pharmaceutics, September 2024, MDPI AG

    Tatjana Srdic-Rajic

  7. DEVELOPMENT OF AN INTEGRATIVE PLATFORM FOR DESIGN OF NOVEL SIRT2 INHIBITORS

    Article • January 2024, University Library in Kragujevac

    Tatjana Srdic-Rajic

  8. Quinoline‐based thiazolyl‐hydrazones target cancer cells through autophagy inhibition

    Article • Archiv der Pharmazie, November 2023, Wiley

    Assoc. Prof. Alfonso T. Garcia-Sosa, Tatjana Srdic-Rajic

  9. Nischarin expression may have differing roles in male and female melanoma patients

    Article • Journal of Molecular Medicine, June 2023, Springer Science + Business Media

    Tatjana Srdic-Rajic

  10. Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma

    Article • Pharmaceuticals, February 2023, MDPI AG

    Tatjana Srdic-Rajic

  11. Synthesis, characterization, andin vivoevaluation of the anticancer activity of a series of 5- and 6-(halomethyl)-2,2′-bipyridine rhenium tricarbonyl complexes

    Article • Dalton Transactions, January 2023, Royal Society of Chemistry

    Tatjana Srdic-Rajic

  12. Synthesis, characterization, and in vivo evaluation of the anticancer activity of a series of 5- and 6-(halomethyl)-2,2'-bipyridine rhenium tricarbonyl complexes.

    Article • December 2022, American Chemical Society (ACS)

    Tatjana Srdic-Rajic

  13. Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation

    Article • Pharmaceutics, November 2022, MDPI AG

    Tatjana Srdic-Rajic

  14. Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma

    Article • October 2022, Cold Spring Harbor Laboratory Press

    Tatjana Srdic-Rajic

  15. Cationic amphiphilic drugs as potential anticancer therapy for PDAC

    Article • European Journal of Cancer, October 2022, Elsevier

    Tatjana Srdic-Rajic

  16. The Effects of Resveratrol-Rich Extracts of Vitis vinifera Pruning Waste on HeLa, MCF-7 and MRC-5 Cells: Apoptosis, Autophagia and Necrosis Interplay

    Article • Pharmaceutics, September 2022, MDPI AG

    Tatjana Srdic-Rajic

  17. Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients

    Article • Growth Factors, September 2022, Taylor & Francis

    Tatjana Srdic-Rajic

  18. Nischarin expression may have differing roles in male and female melanoma patients

    Article • August 2022, Springer Science + Business Media

    Tatjana Srdic-Rajic

  19. Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics

    Article • Journal of Chemical Information and Modeling, April 2022, American Chemical Society (ACS)

    Tatjana Srdic-Rajic

  20. Discovery of 1-benzhydryl piperazine-based HDAC inhibitors with anticancer and antimetastatic properties against human breast cancer: synthesis, molecular modeling, in vitro and in vivo biological evaluation

    Article • March 2022, American Chemical Society (ACS)

    Tatjana Srdic-Rajic

  21. Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention

    Article • Pharmaceutics, January 2022, MDPI AG

    Tatjana Srdic-Rajic

  22. Antibody VH domain sequence analysis by a bioinformatics approach based on electronic amino acid properties may help to predict paratop location

    Article • Immunology Letters, January 2022, Elsevier

    Tatjana Srdic-Rajic

  23. In Vitro Study of Two Edible Polygonoideae Plants: Phenolic Profile, Cytotoxicity, and Modulation of Keap1-Nrf2 Gene Expression

    Article • Foods, April 2021, MDPI AG

    Tatjana Srdic-Rajic

  24. A Model for Potential B-cell Precursors of Broadly Neutralizing HIV-1 Antibodies Selection and Antibody Affinity Maturation

    Article • Aids Reviews, April 2019, Publicidad Permanyer, SLU

    Tatjana Srdic-Rajic

  25. Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics

    Article • Cancer Biology and Medicine, January 2019, Tsinghua University Press

    Tatjana Srdic-Rajic

  26. Author Correction: Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells

    Article • Scientific Reports, October 2018, Springer Science + Business Media

    Tatjana Srdic-Rajic

  27. Antibody Epitope Specificity for dsDNA Phosphate Backbone Is an Intrinsic Property of the Heavy Chain Variable Germline Gene Segment Used

    Article • Frontiers in Immunology, October 2018, Frontiers

    Tatjana Srdic-Rajic

  28. Benzothiazole carbamates and amides as antiproliferative species

    Article • European Journal of Medicinal Chemistry, September 2018, Elsevier

    Tatjana Srdic-Rajic, Marija Mojsin

  29. Conformationally restricted goniofufurone mimics with halogen, azido or benzoyloxy groups at the C-7 position: Design, synthesis and antiproliferative activity

    Article • Tetrahedron, September 2018, Elsevier

    Tatjana Srdic-Rajic

  30. Cooperation of intrathymic T15 idiotype-bearing B and complementary T cells in ontogeny of natural Treg cells involved in establishment of T15 clonal dominance

    Article • Immunology Letters, August 2018, Elsevier

    Tatjana Srdic-Rajic

  31. PO-258 Telmisartan induces melanoma cell apoptosis via generation of ros and has synergistic effects with targeted therapyin vitro

    Article • June 2018, BMJ

    Tatjana Srdic-Rajic

  32. Chemical characterization, antioxidant, genotoxic and in vitro cytotoxic activity assessment of Juniperus communis var. saxatilis

    Article • Food and Chemical Toxicology, February 2018, Elsevier

    Tatjana Srdic-Rajic

  33. Evaluation of anticancer and antimicrobial activities of the Polygonum maritimum ethanol extract

    Article • Archives of Biological Sciences, January 2018, National Library of Serbia

    Tatjana Srdic-Rajic

  34. Novel O-methyl goniofufurone and 7-epi-goniofufurone derivatives: synthesis, in vitro cytotoxicity and SAR analysis

    Article • MedChemComm, January 2018, Royal Society of Chemistry

    Tatjana Srdic-Rajic

  35. IL-2 Mediated Improvement of Cell Antitumor Activity in Advanced Breast Cancer Patients

    Article • The Breast, November 2017, Elsevier

    Tatjana Srdic-Rajic

  36. Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

    Article • Journal of Hepatocellular Carcinoma, July 2017, Dove Medical Press

    MD Aleksandar Bogdanovic, Tatjana Srdic-Rajic

  37. Synthesis and in vitro antitumour activity of crassalactone D, its stereoisomers and novel cinnamic ester derivatives

    Article • European Journal of Medicinal Chemistry, July 2017, Elsevier

    Tatjana Srdic-Rajic

  38. Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells

    Article • Scientific Reports, June 2017, Springer Science + Business Media

    Tatjana Srdic-Rajic

  39. The absence of immunoreactivity to donkey’s milk in patients with recurrent aphthous ulcers and immunoreactivity to cow’s milk

    Article • Food and Agricultural Immunology, March 2017, Taylor & Francis

    Tatjana Srdic-Rajic

  40. Design, synthesis and in vitro antitumour activity of new goniofufurone and 7- epi -goniofufurone mimics with halogen or azido groups at the C-7 position

    Article • European Journal of Medicinal Chemistry, March 2017, Elsevier

    Tatjana Srdic-Rajic

  41. A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin

    Article • Bioorganic & Medicinal Chemistry, July 2016, Elsevier

    Tatjana Srdic-Rajic

  42. Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs

    Article • European Journal of Pharmaceutical Sciences, June 2016, Elsevier

    Tatjana Srdic-Rajic

  43. In vitro assessment of antiproliferative action selectivity of dietary isothiocyanates for tumor versus normal human cells

    Article • Vojnosanitetski pregled, January 2016, National Library of Serbia

    Tatjana Srdic-Rajic

  44. Antioxidants: Role on Health and Prevention

    Article • January 2016, Elsevier

    Tatjana Srdic-Rajic

  45. Rilmenidine suppresses proliferation and promotes apoptosis via the mitochondrial pathway in human leukemic K562 cells

    Article • European Journal of Pharmaceutical Sciences, January 2016, Elsevier

    Tatjana Srdic-Rajic

  46. Synthesis and antiproliferative activity of goniobutenolides A and B, 5-halogenated crassalactone D derivatives and the corresponding 7-epimers

    Article • European Journal of Medicinal Chemistry, January 2016, Elsevier

    Tatjana Srdic-Rajic

  47. Sensitization of K562 Leukemia Cells to Doxorubicin by theViscum albumExtract

    Article • Phytotherapy Research, December 2015, Wiley

    Dr Tamara Zoranovic, Tatjana Srdic-Rajic

  48. Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma

    Article • Journal of Clinical Pathology, October 2015, BMJ

    Tatjana Srdic-Rajic

  49. Acute Effects of Black Currant Consumption on Salivary Flow Rate and Secretion Rate of Salivary Immunoglobulin A in Healthy Smokers

    Article • Journal of Medicinal Food, April 2015, Mary Ann Liebert Inc

    Tatjana Srdic-Rajic

  50. P4.09 * Role of Caspase-3 during TNF-alpha induced membrane molecule shedding from K-562 cells

    Article • Annals of Oncology, March 2015, Oxford University Press (OUP)

    Tatjana Srdic-Rajic

  51. Effects of mistletoe extract on markers of platelet activation and aggregation

    Article • Acta chirurgica iugoslavica, January 2015, National Library of Serbia

    Tatjana Srdic-Rajic

  52. Novel Selenosemicarbazone Metal Complexes Exert Anti-tumor Effect via Alternative, Caspase-independent Necroptotic Cell Death

    Article • Medicinal Chemistry, October 2014, Bentham Science Publishers

    Sinisa Radulovic, Tatjana Srdic-Rajic

  53. PO117 IMPAIRMENT OF IFN GAMMA PRODUCTION AND NK CELL CYTOTOXICITY OF ADVANCED BREAST CANCER PATIENTS

    Article • The Breast, November 2013, Elsevier

    Tatjana Srdic-Rajic

  54. Effects of bioactive‐rich extracts of pomegranate, persimmon, nettle, dill, kale and Sideritis and isolated bioactives on arachidonic acid induced markers of platelet activation and aggregation

    Article • Journal of the Science of Food and Agriculture, September 2013, Wiley

    Tatjana Srdic-Rajic, Prof. Dr. Osman Erol Hayran

  55. Phosphocholine-binding antibody activities are hierarchically encoded in the sequence of the heavy-chain variable region: dominance of self-association activity in the T15 idiotype

    Article • International Immunology, February 2013, Oxford University Press (OUP)

    Tatjana Srdic-Rajic

  56. Imidazoline-1 Receptor Ligands as Apoptotic Agents: Pharmacophore Modeling and Virtual Docking Study

    Article • Combinatorial Chemistry & High Throughput Screening, February 2013, Bentham Science Publishers

    Tatjana Srdic-Rajic

  57. STAT Transcription Factors in Tumor Development and Targeted Therapy of Malignancies

    Article • January 2013, IntechOpen

    Tatjana Srdic-Rajic

  58. Biological evaluation of transdichloridoplatinum( II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin

    Article • Radiology and Oncology, January 2013, De Gruyter

    Tatjana Srdic-Rajic

  59. Cell cycle analysis in patients with Fanconi anemia from Serbia

    Article • Genetika, January 2013, National Library of Serbia

    Tatjana Srdic-Rajic

  60. Biological activity of Aronia melanocarpa antioxidants pre-screening in intervention study design

    Article • Journal of the Serbian Chemical Society, January 2013, National Library of Serbia

    Tatjana Srdic-Rajic

  61. Specific Binding of Paraprotein to Platelet Receptors as a Cause of Platelet Dysfunction in Monoclonal Gammopathies

    Article • Acta Haematologica, January 2013, Karger Publishers

    Tatjana Srdic-Rajic

  62. Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones

    Article • Anti-Cancer Agents in Medicinal Chemistry, October 2012, Bentham Science Publishers

    Tatjana Srdic-Rajic

  63. 105 In Vitro Evaluation of Antioxidant and Antitumoral Activities of Marine Algae Gelidium Sesquipedale and Fucus Spiralis

    Article • European Journal of Cancer, July 2012, Elsevier

    Tatjana Srdic-Rajic

  64. Actinidin, a protease from kiwifruit, induces changes in morphology and adhesion of T84 intestinal epithelial cells

    Article • Phytochemistry, May 2012, Elsevier

    Tatjana Srdic-Rajic

  65. Naturally occurring V region connected antibodies inhibit anti-dsDNA antibody reactivity with dsDNA

    Article • Immunobiology, January 2012, Elsevier

    Tatjana Srdic-Rajic

  66. PS2-076 TNF alpha mediated shadding of CD30 AND CD45 Kfrom -562 cells without caspase-3 activation

    Article • Cytokine, October 2011, Elsevier

    Tatjana Srdic-Rajic

  67. Synthesis, characterization, cytotoxic activity and DNA binding properties of the novel dinuclear cobalt(III) complex with the condensation product of 2-acetylpyridine and malonic acid dihydrazide

    Article • Journal of Inorganic Biochemistry, September 2011, Elsevier

    Iztok Turel, Tatjana Srdic-Rajic

  68. Non-substituted N-heteroaromatic selenosemicarbazone metal complexes induce apoptosis in cancer cells via activation of mitochondrial pathway

    Article • European Journal of Medicinal Chemistry, September 2011, Elsevier

    Tatjana Srdic-Rajic

  69. Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors

    Article • Immunobiology, August 2011, Elsevier

    Tatjana Srdic-Rajic

  70. TNF-α Induced Apoptosis is Accompanied with Rapid CD30 and Slower CD45 Shedding from K-562 Cells

    Article • The Journal of Membrane Biology, January 2011, Springer Science + Business Media

    Tatjana Srdic-Rajic

  71. PS3-33 Dose and time depending effects of TNF-α on shedding of CD45 and CD30 from K-562 cells

    Article • Cytokine, October 2010, Elsevier

    Tatjana Srdic-Rajic

  72. Synthesis, structure and characterization of novel Cd(II) and Zn(II) complexes with the condensation product of 2-formylpyridine and selenosemicarbazide

    Article • Journal of Inorganic Biochemistry, June 2010, Elsevier

    Tatjana Srdic-Rajic

  73. Immunoglobulin G-Reactive Antibodies from Sera of Healthy Individuals Enriched in IgG2 - Therapeutic Potential in HIV-1 Infection

    Article • Current HIV Research, July 2009, Bentham Science Publishers

    Tatjana Srdic-Rajic

  74. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome

    Article • Leukemia Research, August 2007, Elsevier

    Tatjana Srdic-Rajic

  75. Clinical stage-depending decrease of NK cell activity in multiple myeloma patients

    Article • Medical Oncology, May 2007, Springer Science + Business Media

    Tatjana Srdic-Rajic

  76. Anti-IgG Antibodies from Sera of Healthy Individuals Neutralize HIV-1 Primary Isolates.

    Article • Current HIV Research, March 2007, Bentham Science Publishers

    Tatjana Srdic-Rajic

  77. Synthesis and characterization of a novel Pd(II) complex with the condensation product of 2-(diphenylphosphino)benzaldehyde and ethyl hydrazinoacetate. Cytotoxic activity of the synthesized complex and related Pd(II) and Pt(II) complexes

    Article • Journal of Inorganic Biochemistry, November 2006, Elsevier

    Tatjana Srdic-Rajic

  78. Effect of TNF-α on Raji cells at different cellular levels estimated by various methods

    Article • Annals of Hematology, November 2005, Springer Science + Business Media

    Tatjana Srdic-Rajic

  79. Article • Journal of Translational Medicine, January 2005, Springer Science + Business Media

    Tatjana Srdic-Rajic

  80. Modulation of TNF-α activity in tumor PC cells using anti-CD45 and anti-CD95 monoclonal antibodies

    Article • Cancer Letters, October 2004, Elsevier

    Tatjana Srdic-Rajic

  81. Growth Effects of Some Platinum(II) Complexes with Sulfur-Containing Carrier Ligands on MCF7 Human Breast Cancer Cell Line upon Simultaneous Administration with Taxol

    Article • Metal-Based Drugs, January 2002, Hindawi Publishing Corporation

    Tatjana Srdic-Rajic

  82. In-vitro TNF-α effects on hematopoietic cell lines

    Article • European Journal of Cancer, September 2001, Elsevier

    Tatjana Srdic-Rajic

  83. Human Immunodeficiency Virus V3 Peptide-Reactive Antibodies Are Present in Normal HIV-Negative Sera

    Article • AIDS Research and Human Retroviruses, May 1999, Mary Ann Liebert Inc

    Tatjana Srdic-Rajic